Skip to main content
HR 5382 116th Congress House

To create a mechanism whereby insulin manufacturers may sell directly to consumers at current net prices.

Introduced: December 10, 2019 See on congress.gov
Health Health care coverage and accessPrescription drugsRetail and wholesale trades
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 11, 2019
Referred to the Subcommittee on Health.
Dec 10, 2019
Referred to the House Committee on Energy and Commerce.
Dec 10, 2019
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action December 11, 2019

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

This bill requires the federal government to create a mechanism through which insulin manufacturers may sell their products directly to consumers at current net prices.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5382: To create a mechanism whereby insulin manufacturers may sell directly to consumers at current net prices.. 116th Congress. Open America. https://openamerica.io/bill/116-HR-5382/
MLA
"H.R. 5382: To create a mechanism whereby insulin manufacturers may sell directly to consumers at current net prices.." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-5382/.
Bluebook (legal)
H.R. 5382, 116th Cong. (2026), https://openamerica.io/bill/116-HR-5382/.
Markdown link
[H.R. 5382: To create a mechanism whereby insulin manufacturers may sell directly to consumers at current net prices.](https://openamerica.io/bill/116-HR-5382/)
Report a problem